Browsing by Author "Oort, I.M. van"

Now showing items 1-50 of 101

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
Privé, B.M. ; Janssen, M.J.R. ; Oort, I.M. van ; Muselaers, C.H.J.; Jonker, M.A. ; Groot, M. de ; Mehra, N. ; Verzijlbergen, J.F.; Scheenen, T.W.J. ; Zamecnik, P.; Barentsz, J.O. ; Gotthardt, M. ; Noordzij, W.; Vogel, W.V.; Bergman, A.M.; Poel, H.G. van der; Vis, Andre N.; Oprea-Lager, D.E.; Gerritsen, W.R. ; Witjes, J.A. ; Nagarajah, J. et al. sine al.
2020, Article / Letter to editor (BMC Cancer, vol. 20, iss. 1, (2020), article 884)
Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study
Vernooij, R.W.M.; Cremers, R.G.H.M. ; Jansen, H.; Somford, D.M.; Kiemeney, L.A. ; Andel, G. van; Futterer, J.J. ; Oort, I.M. van ; Aben, K.K.H.
2020, Article / Letter to editor (Urologic Oncology-Seminars and Original Investigations, vol. 38, iss. 9, (2020), pp. 735.e17-735.e25)
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
O'Sullivan, Joe M.; Carles, Joan; Cathomas, Richard; Gomez-Iturriaga, Alfonso; Heinrich, Daniel; Kramer, G.; Oort, I.M. van ; Tombal, B.
2020, Article / Letter to editor (European Urology Oncology, vol. 3, iss. 4, (2020), pp. 471-479)
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer
Doelen, M.J. van der ; Velho, Pedro Isaacsson; Slootbeek, P. H.J.; Naga, Samhita Pamidimarri; Bormann, Maren; Helvert, S. van ; Kroeze, L.; Oort, I.M. van ; Gerritsen, W.R. ; Antonarakis, Emmanuel S.; Mehra, N. et al. sine al.
2020, Article / Letter to editor (European Journal of Cancer, vol. 136, (2020), pp. 16-24)
Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategy
Tol-Geerdink, J.J. van ; Oort, I.M. van ; Somford, D.M.; Wijburg, C.J.; Geboers, A.; Uden-Kraan, C.F. van; Vries, M. de ; Stalmeier, P.F.
2020, Article / Letter to editor (Health Informatics Journal, vol. 26, iss. 2, (2020), pp. 1194-1207)
Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands
Kuppen, Malou C.P.; Westgeest, Hans M.; Eertwegh, A.J. van den; Coenen, Jules L. L. M.; Moorselaar, R.J. van; Berg, P. van den; Mehra, N. ; Oort, I.M. van ; Gerritsen, W.R. ; Uyl-de Groot, Carin A.
2020, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 18, iss. 3, (2020), pp. E233-E253)
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
Kuppen, M.C.P.; Westgeest, H.M.; Doelen, M.J. van der ; Eertwegh, A.J. van den; Coenen, J.L.; Aben, K.K.H. ; Bergh, A.C. van den; Bergman, A.M.; Bosch, J. van den; Celik, F.; Hendriks, M.P; Lavalaye, J.; Meer, S.V.; Polee, M.B.; Somford, D.M.; Oort, I.M. van ; Uyl-de Groot, Carin A.; Gerritsen, W.R. et al. sine al.
2020, Article / Letter to editor (Future Oncology, vol. 16, iss. 19, (2020), pp. 1371-1384)
Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study
Santvoort, B.W.H. van; Leenders, G. van; Kiemeney, L.A.L.M. ; Oort, I.M. van ; Wieringa, S.E.; Jansen, H.; Vernooij, R.W.M.; Hulsbergen-van de Kaa, C.A. ; Aben, K.K.H.
2020, Article / Letter to editor (Scandinavian Journal of Urology, vol. 54, iss. 6, (2020), pp. 463-469)
Ga-68-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer
Jong, Anouk C. de; Smits, M. ; Riet, Job van; Futterer, J.J. ; Brabander, Tessa; Hamberg, Paul; Oort, I.M. van ; Wit, R. de; Mehra, N. ; Segbers, Marcel; Veldt, Astrid A.M. van der et al. sine al.
2020, Article / Letter to editor (The Journal of Nuclear Medicine (1978), vol. 61, iss. 11, (2020), pp. 1607-1614)
Introducing decision aids into routine prostate cancer care in the Netherlands: Implementation and patient evaluations from the multi-regional JIPPA initiative
Cuypers, M. ; Al-Itejawi, H.H.M.; Uden-Kraan, C.F. van; Stalmeier, P.F.M. ; Lamers, R.E.D.; Oort, I.M. van ; Somford, D.M.; Moorselaar, R.J.A. van; Verdonck-de Leeuw, I.M.; Poll-Franse, L.V. van de; Tol-Geerdink, J.J. van ; Vries, M. de et al. sine al.
2020, Article / Letter to editor (Journal of Cancer Education, vol. 35, iss. 6, (2020), pp. 1141-1148)
Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting
Aluwini, S.S.; Mehra, N. ; Lolkema, M.P.; Oprea-Lager, D.E.; Yakar, D.; Stoevelaar, H.; Poel, H.G. van der ; Busstra, M.; Jong, I.J. de; Reijke, T. de; Vries, K. de; Heijmink, S.; Jenster, G.; Klaver, S.; Kneppers, J.; Lavalaye, J.; Leyten, G.; Moonen, L.; Nagaraj, J.; Noordzij, W.; Osanto, S.; Oving, I.; Schaake, E.; Scheenen, T.W.J. ; Schoots, I.; Sedelaar, M. ; Somford, D.M.; Berkmortel, F.W. van den ; Hulle, T. van der; Voort van Zyp, J.R.N. van der; Leeuwen, P. van; Moorselaar, J. van; Oort, I.M. van ; Vogel, W.; Westgeest, H. et al. sine al.
2020, Article / Letter to editor (European Urology Oncology, vol. 3, iss. 2, (2020), pp. 231-238)
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Gillessena, Silke; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Oort, I.M. van ; Zapatero, Almudena; Omlind, Aurelius
2020, Article / Letter to editor (European Urology, vol. 77, iss. 4, (2020), pp. 508-547)
High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
Westdorp, H.; Creemers, J.H.A.; Oort, I.M. van ; Mehra, N. ; Hins-de Bree, S.M.; Figdor, C.G. ; Witjes, J.A. ; Schreibelt, G. ; Vries, I.J.M. de ; Gerritsen, W.R. ; Ottevanger, P.B. et al. sine al.
2020, Article / Letter to editor (Frontiers in Oncology, vol. 10, (2020), article 536700)
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer
Smits, M. ; Ekici, K.; Pamidimarri Naga, S. ; Oort, I.M. van ; Sedelaar, M. ; Schalken, J.A. ; Nagarajah, J.; Scheenen, T.W.J. ; Gerritsen, W.R. ; Futterer, J.J. ; Mehra, N. et al. sine al.
2020, Article / Letter to editor (Cancers, vol. 12, iss. 12, (2020), article 3756)
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study
Benoist, G.E. ; Oort, I.M. van ; Boerrigter, E. ; Verhaegh, G.W. ; Hooij, O. van ; Groen, L.N. ; Mehra, N. ; Gerritsen, W.R. ; Erp, N.P. van ; Schalken, J.A.
2020, Article / Letter to editor (Clinical Chemistry, vol. 66, iss. 6, (2020), pp. 842-851)
(68)Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients
Steenbergen, T.R.F. van; Smits, M; Scheenen, T.W.J. ; Oort, I.M. van ; Nagarajah, J.; Rovers, M.M. ; Mehra, N. ; Futterer, J.J.
2020, Article / Letter to editor (Cardiovascular and Interventional Radiology, vol. 43, iss. 1, (2020), pp. 147-154)
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
Benoist, G.E. ; Oort, I.M. van ; Burger, D.M. ; Mehra, N. ; Erp, N.P. van
2020, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 85, iss. 4, (2020), pp. 753-760)
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Lubberman, F.J.E. ; Benoist, G.E. ; Gerritsen, W.R. ; Burger, D.M. ; Mehra, N. ; Hamberg, P.; Oort, I.M. van ; Erp, N. van
2019, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 84, iss. 6, (2019), pp. 1179-1185)
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
Dessel, Lisanne F. van; Riet, Job van; Smits, M. ; Zhu, Yanyun; Hamberg, P.; Heijden, Michiel S. van der; Oort, Inge M. van ; Mehra, N. ; Lolkema, M.P.
2019, Article / Letter to editor (Nature Communications, vol. 10, (2019), article 5251)
Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands
Westgeest, H.M.; Kuppen, M.C.P.; Eertwegh, A.J. van den; Wit, R. de; Coenen, J.; Berg, H.Pieter van den; Mehra, N. ; Oort, I.M. van ; Fossion, L.; Hendriks, M.P; Bloemendal, H.J.; Luijtgaarden, A.C.M. van de; Huinink, D. Ten Bokkel; Bergh, A. von; Bosch, J; Polee, M.B.; Weijl, N.; Bergman, A.M.; Groot, C.A.R.; Gerritsen, W.R. et al. sine al.
2019, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 17, iss. 5, (2019), pp. e946-e956)
High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naive Men: The Next Step in Magnetic Resonance Imaging Accessibility
Leest, M.M. van der; Israël, B. ; Cornel, Erik Bastiaan; Zamecnik, P.; Schoots, Ivo G.; Lelij, Hans van der; Rovers, M.M. ; Oort, I.M. van ; Sedelaar, J.P.M. ; Hulsbergen-van de Kaa, C.A. ; Hannink, G.J. ; Veltman, Jeroen; Barentsz, J. et al. sine al.
2019, Article / Letter to editor (European Urology, vol. 76, iss. 5, (2019), pp. 574-581)
The Combination of Enzalutamide and Opioids: A Painful Pitfall?
Benoist, G.E. ; Oort, I.M. van ; Burger, D.M. ; Koch, B.C.; Mehra, N. ; Erp, N.P. van
2019, Article / Letter to editor (European Urology, vol. 75, iss. 2, (2019), pp. 351-352)
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors
Jansen, Hanneke; Oort, I.M. van ; Andel, George van; Wijsman, Bart P.; Pos, Floris J.; Hulshof, Maarten C.C.M.; Hulsbergen-van de Kaa, C.A. ; Futterer, J.J. ; Kiemeney, L.A. ; Aben, K.K.H.
2019, Article / Letter to editor (Prostate Cancer and Prostatic Diseases, vol. 22, iss. 2, (2019), pp. 337-343)
Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up
Hamoen, E.H.J.; Hoeks, C.M.A. ; Somford, D.M.; Oort, Inge M. van ; Vergunst, Henk; Oddens, Jorg R.; Witjes, J.A. ; Rovers, M.M. ; Hulsbergen-van de Kaa, C.A. ; Barentsz, J.O.
2019, Article / Letter to editor (European Urology Focus, vol. 5, iss. 3, (2019), pp. 407-415)
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Westdorp, H.; Creemers, J.H.A.; Oort, I.M. van ; Schreibelt, G. ; Gorris, M.A.J.; Mehra, N. ; Simons, M. ; Goede, A.L. de ; Rossum, M.M. van ; Croockewit, A.J. ; Figdor, C.G. ; Witjes, J.A. ; Aarntzen, E.H.J.G. ; Mus, R.D.M. ; Bruning, M.; Petry, K.; Gotthardt, M. ; Barentsz, J.O. ; Vries, I.J.M. de ; Gerritsen, W.R. et al. sine al.
2019, Article / Letter to editor (Journal for Immunotherapy of Cancer, vol. 7, iss. 1, (2019), pp. 302)
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
de Wit, R.; de Bono, J.; Sternberg, C.N. ; Fizazi, K.; Tombal, B.; Wulfing, C.; Kramer, G.; Eymard, J.C.; Bamias, A.; Carles, J.; Iacovelli, R.; Melichar, B.; Sverrisdottir, A.; Theodore, C.; Feyerabend, S.; Helissey, C.; Ozatilgan, A.; Oort, I.M. van ; Geffriaud-Ricouard, C.; Castellano, D. et al. sine al.
2019, Article / Letter to editor (The New England Journal of Medicine, vol. 381, iss. 26, (2019), pp. 2506-2518)
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
Leest, M.M. van der; Cornel, Erik; Israël, B. ; Hendriks, R.J.; Padhani, Anwar R.; Hoogenboom, M.; Zamecnik, P.; Oort, I.M. van ; Sedelaar, M. ; Hannink, G.J. ; Rovers, M.M. ; Hulsbergen-van de Kaa, C.A. ; Barentsz, J.O. et al. sine al.
2019, Article / Letter to editor (European Urology, vol. 75, iss. 4, (2019), pp. 570-578)
Nationwide treatment patterns and survival of older patients with prostate cancer
Vernooij, R.W.M.; Oort, I.M. van ; Reijke, T.M. de; Aben, K.K.H.
2019, Article / Letter to editor (Journal of Geriatric Oncology, vol. 10, iss. 2, (2019), pp. 252-258)
Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives
Doelen, M.J. van der ; Mehra, N. ; Hermsen, Rick; Janssen, M.J.R. ; Gerritsen, W.R. ; Oort, I.M. van
2019, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 17, iss. 2, (2019), pp. 79-87)
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
Heinrich, Daniel; Bektic, Jasmin; Bergman, A.M.; Caffo, Orazio; Cathomas, Richard; Chi, Kim N.; Oort, I.M. van ; Nilsson, Sten
2018, Article / Letter to editor (Clinical Genitourinary Cancer, vol. 16, iss. 1, (2018), pp. E223-E231)
Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
Hendriks, R.J.; Dijkstra, S. ; Smit, F.P. ; Vandersmissen, Johan; Voorde, Hendrik Van de; Mulders, P.F.A. ; Oort, I.M. van ; Criekinge, W. van; Schalken, J.A.
2018, Article / Letter to editor (Prostate, vol. 78, iss. 5, (2018), pp. 336-342)
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice
Doelen, M.J. van der ; Kuppen, Malou C.P.; Jonker, M.A. ; Mehra, N. ; Janssen, M.J.R. ; Oort, I.M. van ; Gerritsen, W.R.
2018, Article / Letter to editor (Clinical Nuclear Medicine, vol. 43, iss. 1, (2018), pp. 9-16)
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap
Benoist, G.E. ; Oort, I.M. van ; Smeenk, Stella; Javad, Adrian; Somford, D.M.; Burger, D.M. ; Mehra, N. ; Erp, N. van
2018, Article / Letter to editor (British Journal of Clinical Pharmacology, vol. 84, iss. 1, (2018), pp. 122-129)
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate Cancer
Benoist, G.E. ; Meulen, E. van der ; Oort, I.M. van ; Beumer, J.H.; Somford, D.M.; Schalken, J.A. ; Burger, D.M. ; Erp, N.P. van
2018, Article / Letter to editor (Therapeutic Drug Monitoring, vol. 40, iss. 2, (2018), pp. 222-229)
Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer
Westdorp, H.; Kuip, E.J.M. ; Oort, I.M. van ; Kramers, C. ; Gerritsen, W.R. ; Vissers, K.C.P.
2018, Article / Letter to editor (Journal of Pain and Symptom Management, vol. 55, iss. 4, (2018), pp. e6-e8)
Fear of cancer recurrence: a significant concern among partners of prostate cancer survivors
Wal, M.A. van de; Langenberg, S.M.; Gielissen, M.F. ; Thewes, B.; Oort, I.M. van ; Prins, J.B.
2017, Article / Letter to editor (Psycho-Oncology, vol. 26, iss. 12, (2017), pp. 2079-2085)
A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
Hendriks, R.J.; Leest, M.M.G. van der; Dijkstra, S. ; Barentsz, J.O. ; Criekinge, W. van; Kaa, C.A. van de ; Schalken, J.A. ; Mulders, P.F.A. ; Oort, I.M. van
2017, Article / Letter to editor (Prostate, vol. 77, iss. 14, (2017), pp. 1401-1407)
Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model
Dijkstra, S. ; Govers, T.M. ; Hendriks, R.J.; Schalken, J.A. ; Criekinge, W. van; Neste, L. Van; Grutters, J.P.C. ; Sedelaar, J.P.M. ; Oort, I.M. van
2017, Article / Letter to editor (BJU International, vol. 120, iss. 5, (2017), pp. 659-665)
Novel use of Twitter to disseminate and evaluate adherence to clinical guidelines by the European Association of Urology
Loeb, S.; Roupret, M.; Oort, I.M. van ; N'Dow, J.; Gurp, M. van; Bloemberg, J.; Darraugh, J.; Ribal, M.J.
2017, Article / Letter to editor (BJU International, vol. 119, iss. 6, (2017), pp. 820-822)
Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions
Hendriks, R.J.; Oort, I.M. van ; Schalken, J.A.
2017, Article / Letter to editor (Prostate Cancer and Prostatic Diseases, vol. 20, iss. 1, (2017), pp. 12-19)
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation
Badrising, S.K.; Noort, V van; Eertwegh, A.J. van den; Hamberg, P.; Oort, I.M. van ; Berg, H.P. van den; Los, M.; Aarts, M.J.; Coenen, J.L.; Gelderblom, H.; Jong, I.J. de; Kerver, E.D.; Vrijaldenhoven, S.; Voorthuizen, T. van; Warmerdam, F.; Haanen, J.B.; Bergman, A.M. et al. sine al.
2016, Article / Letter to editor (Prostate, vol. 76, iss. 1, (2016), pp. 32-40)
Fear of cancer recurrence in prostate cancer survivors
Wal, M.A. van de; Oort, I.M. van ; Schouten, J.; Thewes, B.; Gielissen, M.F.M. ; Prins, J.B.
2016, Article / Letter to editor (Acta Oncologica, vol. 55, iss. 7, (2016), pp. 821-827)
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer
Badrising, S.K.; Noort, V van; Hamberg, P.; Coenen, J.L.; Aarts, M.J.; Oort, I.M. van ; Eertwegh, A.J. van den; Los, M.; Berg, H.P. van den; Gelderblom, H.; Vrijaldenhoven, S.; Kerver, E.D.; Voorthuizen, T. van; Jong, I.J. de; Haanen, J.B.; Bergman, A.M. et al. sine al.
2016, Article / Letter to editor (Oncology (Basel: 1948), vol. 91, iss. 5, (2016), pp. 267-273)
PREDICT: model for prediction of survival in localized prostate cancer
Kerkmeijer, L.G.; Monninkhof, E.M.; Oort, I.M. van ; Poel, H.G. van der; Meerleer, G. de; Vulpen, M. van
2016, Article / Letter to editor (World Journal of Urology, vol. 34, iss. 6, (2016), pp. 789-795)
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Benoist, G.E. ; Hendriks, R.J.; Mulders, P.F.A. ; Gerritsen, W.R. ; Somford, D.M.; Schalken, J.A. ; Oort, I.M. van ; Burger, D.M. ; Erp, N. van
2016, Article / Letter to editor (Clinical Pharmacokinetics, vol. 55, iss. 11, (2016), pp. 1369-1380)
Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial
Tol-Geerdink, J.J. van ; Leer, J.W.H. ; Wijburg, C.J.; Oort, I.M. van ; Vergunst, H.; Lin, E.J. van; Witjes, J.A. ; Stalmeier, P.F.M.
2016, Article / Letter to editor (Health Expectations, vol. 19, iss. 2, (2016), pp. 459-470)
Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
Hendriks, R.J.; Dijkstra, S. ; Jannink, S.A.; Steffens, M.G.; Oort, I.M. van ; Mulders, P.F.A. ; Schalken, J.A.
2016, Article / Letter to editor (Clinical Chemistry and Laboratory Medicine, vol. 54, iss. 3, (2016), pp. 483-492)
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Neste, L. Van; Hendriks, R.J.; Dijkstra, S. ; Trooskens, G.; Cornel, E.B.; Jannink, S.A.; Jong, H. de; Hessels, D.; Smit, F.P.; Melchers, W.J.G. ; Leyten, G.; Reijke, T.M. de; Vergunst, H.; Kil, P.; Knipscheer, B.C. ; Kaa, C.A. van de ; Mulders, P.F.A. ; Oort, I.M. van ; Criekinge, W. van; Schalken, J.A. et al. sine al.
2016, Article / Letter to editor (European Urology, vol. 70, iss. 5, (2016), pp. 740-748)
The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited
Cremers, R.G.H.M. ; Aben, K.K.H. ; Oort, I.M. van ; Sedelaar, J.P.M. ; Vasen, H.F.A.; Vermeulen, S.H. ; Kiemeney, L.A.L.M.
2016, Article / Letter to editor (Prostate, vol. 76, iss. 10, (2016), pp. 897-904)
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients
Ploussard, G.; Isbarn, H.; Briganti, A.; Sooriakumaran, P.; Surcel, C.I.; Salomon, L.; Freschi, M.; Mirvald, C.; Poel, H.G. van der; Jenkins, A.; Ost, P.; Oort, I.M. van ; Yossepowitch, O.; Giannarini, G.; Bergh, R.C. van den et al. sine al.
2015, Article / Letter to editor (Urologic Oncology-Seminars and Original Investigations, vol. 33, iss. 2, (2015), pp. 71.e1-9)

Now showing items 1-50 of 101

Search Repository

Browse

All of Repository

Radboud Repository

Browsing by Author "Oort, I.M. van"

Search Repository

Browse

All of Repository